硼中子俘获治疗人脑胶质母细胞瘤的前景和困惑OA北大核心CSTPCD
Boron neutron capture therapy for glioblastoma of prospects and confused
硼中子俘获疗法是一种可以选择性杀伤肿瘤细胞的放射疗法,其产生的α粒子对临床治疗新诊断和复发的脑胶质母细胞瘤有较好的疗效.发达国家20世纪五六十年代就已进入临床试验,但一直受到硼携带载体和中子源发展的限制.现就其治疗脑胶质母细胞瘤的前景做一综述.
Boron neutron capture therapy (BNCT) is a selective radiotherapy of damage tumor cells, and a particle produced by which is effective to prevent glioblastoma multiform recurrence. Clinical trails of BNCT were carried out in fifties to sixties of 20 century in developed countries, but it was limited because of the development of boron carrier and neutron source. This is a review of BNCT prospect on glioblastoma multiform.
周幽心;孙婷;杨伟廉;杜子威
苏州大学附属第一医院神经外科暨脑神经研究室,江苏苏州215006苏州大学附属第一医院神经外科暨脑神经研究室,江苏苏州215006苏州大学附属第一医院神经外科暨脑神经研究室,江苏苏州215006苏州大学附属第一医院神经外科暨脑神经研究室,江苏苏州215006
医药卫生
硼中子俘获疗法多形性胶质母细胞瘤胶质瘤干细胞
boron neutron capture therapyglioblastoma multiformglioma stem cells
《中国工程科学》 2012 (8)
82-84,3
江苏省医学领军人才与创新团队项目(K201106)苏州大学青年教师自然科学基金项目(Q312202810)
评论